MindMaze Therapeutics Holding SA annual ebitda
2021
2022
2023
MindMaze Therapeutics Holding SA EBITDA Growth & History (MMTZF)
MindMaze Therapeutics Holding SA's calculated EBITDA was −CHF107.5M for fiscal 2023.
View full MindMaze Therapeutics Holding SA company overviewMindMaze Therapeutics Holding SA annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −CHF107.5M | −CHF59.3M | — |
| 2022 | 2022-12-31 | −CHF48.2M | −CHF15.9M | — |
| 2021 | 2021-12-31 | −CHF32.3M | — | — |
MindMaze Therapeutics Holding SA ebitda trends
Between the periods ended 2021-12-31 and 2023-12-31, MindMaze Therapeutics Holding SA's ebitda decreased from −CHF32.3M to −CHF107.5M, a change of −CHF75.2M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MindMaze Therapeutics Holding SA source filings ↗